Aqueous humor and plasma adiponectin levels in proliferative diabetic retinopathy patients

Current Eye Research

Volumn 37, Issue 9, 2012, Pages 803-808

  Mao, Danna ^a   Peng, Hui ^a   Li, Qiuhong ^b   Wang, Jun ^a   Li, Pinghua ^a   Hu, Ke ^a   Zhang, Xuedong ^a   Lei, Bo ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Adiponectin; Aqueous humor; Diabetes mellitus; Diabetic retinopathy; Retina

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; MESSENGER RNA;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; BLOOD RETINA BARRIER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENILE CATARACT;

ADIPONECTIN; AQUEOUS HUMOR; BLOOD-RETINAL BARRIER; DIABETIC RETINOPATHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VITREORETINOPATHY, PROLIFERATIVE;

EID: 84864838967     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2012.676700     Document Type: Article

References (32)

1. Sheetz MJ, King GL. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 2002;288:2579-2588.
2. Spranger J, Pfeiffer AF. New concepts in pathogenesis and treatment of diabetic retinopathy. Exp Clin Endocrinol Diabetes 2001;109 Suppl 2:S438-S450.
3. Gariano RF, Gardner TW. Retinal angiogenesis in development and disease. Nature 2005;438:960-966.
4. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: An adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002;13:84-89.
5. Dez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003;148:293-300.
6. Ukkola O, Santaniemi M. Adiponectin: A link between excess adiposity and associated comorbidities J Mol Med 2002;80:696-702.
7. Stefan N, Stumvoll M. Adiponectin - Its role in metabolism and beyond. Horm Metab Res 2002;34:469-474.
8. Frystyk J, Tarnow L, Hansen TK, Parving HH, Flyvbjerg A. Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia 2005;48:1911-1918.
9. Hotta K, Funahashi T, Arita Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595-1599.
10. Hotta K, Funahashi T, Bodkin NL et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001;50:1126-1133.
11. Higuchi A, Ohashi K, Kihara S, Walsh K, Ouchi N. Adiponectin suppresses pathological microvessel formation in retina through modulation of tumor necrosis factor-alpha expression. Circ Res 2009;104:1058-1065.
12. Bora PS, Kaliappan S, Lyzogubov VV et al. Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin. FEBS Lett 2007;581:1977-1982.
13. Yilmaz MI, Sonmez A, Acikel C et al. Adiponectin may play a part in the pathogenesis of diabetic retinopathy. Eur J Endocrinol 2004;151:135-140.
14. Zietz B, Buechler C, Kobuch K, Neumeier M, Schmerich J, Schfler A. Serum levels of adiponectin are associated with diabetic retinopathy and with adiponectin gene mutations in Caucasian patients with diabetes mellitus type 2. Exp Clin Endocrinol Diabetes 2008;116:532-536.
15. Kato K, Osawa H, Ochi M et al. Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy. Clin Endocrinol (Oxf) 2008;68:442-449.
16. Chowdhury UR, Madden BJ, Charlesworth MC, Fautsch MP. Proteome analysis of human aqueous humor. Invest Ophthalmol Vis Sci 2010;51:4921-4931.
17. Sharma RK, Rogojina AT, Chalam KV. Multiplex immunoassay analysis of biomarkers in clinically accessible quantities of human aqueous humor. Mol Vis 2009;15:60-69.
18. Watkins PJ. Retinopathy. BMJ 2003;326:924-926.
19. Fautsch MP, Johnson DH. Characterization of myocilinmyocilin interactions. Invest Ophthalmol Vis Sci 2001;42: 2324-2331.
20. Fautsch MP, Vrabel AM, Peterson SL, Johnson DH. In vitro and in vivo characterization of disulfide bond use in myocilin complex formation. Mol Vis 2004;10:417-425.
21. Yamauchi T, Kamon J, Ito Y et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003;423:762-769.
22. Ranscht B, Dours-Zimmermann MT. T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region. Neuron 1991;7: 391-402.
23. Kos K, Harte AL, da Silva NF et al. Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus. J Clin Endocrinol Metab 2007;92:1129-1136.
24. Neumeier M, Weigert J, Buettner R et al. Detection of adiponectin in cerebrospinal fluid in humans. Am J Physiol Endocrinol Metab 2007;293:E965-E969.
25. Kusminski CM, McTernan PG, Schraw T et al. Adiponectin complexes in human cerebrospinal fluid: Distinct complex distribution from serum. Diabetologia 2007;50:634-642.
26. El Sanharawi M, Kowalczuk L, Touchard E, Omri S, De Kozak Y, Behar-Cohen F. Protein delivery for retinal diseases: From basic considerations to clinical applications. Prog Retin Eye Res 2010;29:443-465.
27. Waki H, Yamauchi T, Kamon J et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 2003;278:40352-40363.
28. Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: Vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 1998;47:1953-1959.
29. Cunha-Vaz J, Faria De Abreu JR, Campos AJ. Early breakdown of the blood-retinal barrier in diabetes. Br J Ophthalmol 1975;59:649-656.
30. Engler C, Krogsaa B, Lund-Andersen H. Blood-retina barrier permeability and its relation to the progression of diabetic retinopathy in type 1 diabetics. An 8-year follow-up study. Graefes Arch Clin Exp Ophthalmol 1991;229:442-446.
31. Vozarova De Courten B, Hanson RL, Funahashi T et al. Common Polymorphisms in the Adiponectin Gene ACDC Are Not Associated With Diabetes in Pima Indians. Diabetes 2005;54:284-289.
32. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005;26:439-451.